Details

---

Manufacturer
Jiangsu Hansoh Pharmaceutical Group Co. Ltd(CHINA)

Registraction Number
MAL24106021ACZ

Content:

• Active Ingredient: Fulvestrant 250mg/5ml (50mg/ml)
• Excipients: Various inactive ingredients to stabilize the solution

Indications:

• Monotherapy: Used for the treatment of hormone receptor-positive (HR-positive) advanced breast cancer in postmenopausal women with disease progression following anti-estrogen therapy.
• Combination Therapy: May be used in combination with other therapies as per the oncologist's recommendation.

Instructions:
Dosage and Administration: Administered as a single intramuscular injection once monthly. The dose is typically 500mg (2ml) administered as two 1ml injections into the buttocks.

1. Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
2. Handling: Use aseptic techniques to avoid contamination. Dispose of syringes and needles safely after use.